Last 47 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 17.05 | 14.41 | 9.15 | 35.48 | 15.18 | 12.60 | 11.32 | 50.95 | 29.82 | 13.75 | 13.52 | 32.48 | 19.97 | 14.26 | 13.85 | 35.72 | 17.15 | 17.93 | 16.78 | 25.03 | 15.20 |
| — | +14.4% | -19.1% | -30.4% | -49.1% | -8.4% | -16.3% | +56.9% | +49.3% | -3.5% | -2.4% | -9.1% | +16.4% | -20.5% | -17.4% | +42.7% | +12.8% | +36.2% | +25.4% | -31.7% | -80.3% | |
| P/S Ratio | 0.47 | 0.42 | 0.32 | 0.39 | 0.36 | 0.44 | 0.51 | 0.47 | 0.67 | 0.72 | 0.71 | 0.65 | 0.60 | 0.60 | 0.65 | 0.77 | 0.69 | 0.76 | 0.79 | 0.78 | 0.64 |
| — | -5.4% | -36.4% | -16.7% | -46.4% | -39.1% | -29.1% | -28.0% | +11.7% | +19.8% | +9.1% | -15.9% | -12.8% | -20.4% | -17.1% | -0.4% | +7.6% | +9.0% | +14.6% | +22.8% | +16.8% | |
| P/B Ratio | 2.16 | 1.87 | 1.47 | 1.77 | 1.66 | 2.00 | 2.32 | 2.06 | 2.76 | 2.99 | 2.98 | 2.82 | 2.67 | 2.76 | 2.94 | 3.41 | 3.05 | 3.27 | 3.33 | 3.15 | 2.56 |
| — | -6.5% | -36.8% | -14.2% | -40.1% | -33.0% | -22.3% | -27.1% | +3.4% | +8.4% | +1.4% | -17.1% | -12.5% | -15.8% | -11.7% | +8.1% | +19.2% | +21.5% | +26.9% | +29.7% | +27.2% | |
| P/FCF | 29.26 | 12.96 | 3.94 | — | 23.54 | 12.29 | 30.09 | 55.50 | 12.92 | 254.98 | 17.87 | — | 11.22 | 16.51 | 4.47 | — | 5.95 | 13.61 | 13.12 | 21.36 | 10.21 |
| — | +5.4% | -86.9% | — | +82.1% | -95.2% | +68.4% | — | +15.1% | +1444.6% | +300.0% | — | +88.5% | +21.3% | -66.0% | — | -41.7% | -19.4% | +35.6% | +274.6% | — | |
| EV / EBITDA | 12.07 | 12.09 | 7.82 | 25.71 | 11.23 | 9.08 | 8.63 | 20.40 | 17.21 | 10.98 | 10.02 | 19.50 | 12.66 | 9.76 | 9.54 | 20.34 | 11.34 | 12.51 | 12.12 | 17.12 | 10.87 |
| — | +33.1% | -9.4% | +26.0% | -34.7% | -17.3% | -13.8% | +4.6% | +35.9% | +12.5% | +5.0% | -4.2% | +11.7% | -22.0% | -21.3% | +18.8% | +4.3% | +25.8% | +22.7% | -22.5% | -53.7% | |
| EV / EBIT | 14.38 | 13.18 | 8.15 | 43.67 | 13.71 | 10.39 | 9.66 | 28.98 | 20.99 | 11.30 | 11.05 | 26.06 | 15.48 | 11.32 | 11.08 | 27.89 | 13.52 | 14.62 | 13.85 | 20.91 | 12.60 |
| — | +26.8% | -15.6% | +50.7% | -34.7% | -8.1% | -12.6% | +11.2% | +35.6% | -0.2% | -0.2% | -6.6% | +14.5% | -22.5% | -20.0% | +33.4% | +7.3% | +30.9% | +25.3% | -30.7% | -66.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 25.6% | 89.1% | 18.1% | 23.5% | 24.8% | 26.3% | 27.8% | 26.3% | 27.0% | 30.0% | 28.3% | 26.5% | 28.6% | 27.6% | 27.0% | 24.4% | 26.3% | 25.5% | 25.9% | 24.7% | 25.6% |
| — | +239.4% | -34.7% | -10.6% | -8.2% | -12.3% | -1.7% | -0.9% | -5.5% | +8.4% | +4.7% | +8.8% | +8.5% | +8.5% | +4.3% | -1.4% | +2.8% | -5.2% | -3.5% | +1.7% | -3.1% | |
| Operating Margin | 4.1% | 4.1% | 5.3% | 1.2% | 3.5% | 5.3% | 6.4% | 2.1% | 3.8% | 6.9% | 7.5% | 3.0% | 4.5% | 6.2% | 6.8% | 3.2% | 5.9% | 6.0% | 6.6% | 4.4% | 6.1% |
| — | -22.7% | -17.5% | -43.9% | -8.6% | -23.7% | -14.6% | -29.5% | -15.1% | +12.1% | +10.6% | -7.4% | -23.8% | +2.6% | +3.4% | -26.8% | -4.5% | -20.3% | -10.0% | +72.5% | +209.7% | |
| Net Margin | 2.8% | 2.9% | 3.5% | 1.1% | 2.3% | 3.5% | 4.5% | 0.9% | 2.3% | 5.3% | 5.3% | 2.0% | 3.0% | 4.2% | 4.7% | 2.2% | 4.0% | 4.2% | 4.7% | 3.1% | 4.2% |
| — | -17.2% | -21.3% | +19.5% | +4.2% | -33.6% | -15.4% | -54.2% | -25.2% | +24.2% | +11.8% | -7.3% | -25.0% | +0.1% | +0.4% | -30.3% | -4.7% | -20.0% | -8.7% | +79.5% | +491.2% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 13.3% | 3.3% | 4.0% | 1.2% | 2.7% | 4.0% | 5.2% | 1.0% | 2.4% | 5.5% | 5.6% | 2.2% | 3.4% | 4.9% | 5.4% | 2.4% | 4.5% | 4.6% | 5.0% | 3.2% | 4.3% |
| — | -18.5% | -22.9% | +26.7% | +14.7% | -27.3% | -7.3% | -55.4% | -29.7% | +13.3% | +4.0% | -8.1% | -24.8% | +7.4% | +8.7% | -24.4% | +4.7% | -12.4% | -0.1% | +92.5% | +555.9% | |
| ROA | 4.8% | 1.2% | 1.4% | 0.4% | 1.0% | 1.4% | 1.8% | 0.4% | 0.9% | 2.0% | 2.0% | 0.8% | 1.2% | 1.7% | 1.9% | 0.8% | 1.6% | 1.6% | 1.8% | 1.2% | 1.6% |
| — | -19.6% | -22.7% | +25.1% | +9.8% | -29.5% | -9.3% | -54.1% | -24.6% | +20.4% | +8.3% | -7.2% | -25.4% | +4.5% | +3.9% | -27.7% | +1.2% | -13.0% | -0.1% | +84.5% | +511.0% | |
| ROIC | 9.1% | 2.3% | 3.0% | 0.6% | 2.0% | 3.0% | 3.6% | 1.1% | 2.0% | 3.6% | 4.0% | 1.7% | 2.6% | 3.7% | 3.9% | 1.8% | 3.3% | 3.2% | 3.4% | 2.2% | 3.0% |
| — | -22.5% | -17.2% | -41.4% | -2.2% | -17.1% | -9.8% | -33.9% | -22.9% | -1.5% | +1.2% | -6.5% | -19.6% | +16.0% | +16.4% | -17.4% | +8.9% | -13.4% | -5.7% | +81.9% | +238.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.75 | 0.69 | 0.72 | 0.75 | 0.73 | 0.69 | 0.70 | 0.79 | 0.62 | 0.65 | 0.65 | 0.68 | 0.69 | 0.70 | 0.72 | 0.71 | 0.71 | 0.70 | 0.69 | 0.69 | 0.69 |
| — | +0.2% | +2.7% | -4.4% | +17.7% | +5.2% | +8.3% | +16.7% | -9.7% | -6.2% | -10.2% | -4.7% | -2.9% | -0.8% | +4.3% | +3.1% | +3.0% | -1.5% | -5.7% | +4.7% | +2.7% | |
| Debt / EBITDA | 3.44 | 14.29 | 11.48 | 33.67 | 14.97 | 10.02 | 8.54 | 24.33 | 13.30 | 8.24 | 7.48 | 15.83 | 11.29 | 8.53 | 8.13 | 14.77 | 9.11 | 9.27 | 8.72 | 12.74 | 9.63 |
| — | +42.6% | +34.5% | +38.4% | +12.6% | +21.6% | +14.1% | +53.7% | +17.8% | -3.4% | -8.0% | +7.2% | +23.9% | -8.0% | -6.8% | +15.9% | -5.4% | +6.3% | -7.3% | -36.2% | -60.6% | |
| Current Ratio | 1.24 | 1.52 | 1.48 | 1.24 | 1.29 | 1.18 | 1.14 | 1.10 | 1.03 | 1.00 | 0.87 | 0.97 | 1.05 | 1.01 | 1.08 | 1.09 | 1.08 | 0.96 | 0.96 | 0.94 | 1.01 |
| — | +28.5% | +30.3% | +12.7% | +25.4% | +18.0% | +31.2% | +13.2% | -1.8% | -1.1% | -19.7% | -11.0% | -3.0% | +5.2% | +12.3% | +16.2% | +7.4% | -6.8% | -31.8% | -17.6% | -0.2% | |
| Quick Ratio | 1.24 | 1.52 | 1.48 | 1.24 | 1.29 | 1.18 | 1.14 | 1.10 | 1.03 | 1.00 | 0.87 | 0.97 | 1.05 | 1.01 | 1.08 | 1.09 | 1.08 | 0.96 | 0.96 | 0.94 | 1.01 |
| — | +28.5% | +30.3% | +12.7% | +25.4% | +18.0% | +31.2% | +13.2% | -1.8% | -1.1% | -19.7% | -11.0% | -3.0% | +5.2% | +12.3% | +16.2% | +7.4% | -6.8% | -31.8% | -17.6% | -0.2% | |
| Interest Coverage | 5.79 | 35.59 | 7.45 | 1.59 | 5.01 | 7.72 | 9.13 | 2.78 | 5.58 | 11.66 | 12.09 | 4.86 | 7.39 | 10.35 | 11.43 | 5.56 | 10.99 | 11.20 | 12.47 | 8.00 | 10.93 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ELV stock.
Elevance Health Inc.'s current P/E is 17.0x. The average P/E over the last 4 quarters is 18.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Elevance Health Inc.'s current operating margin is 4.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Elevance Health Inc.'s business trajectory between earnings reports.